The Effect Of Kristeller Maneuver On Maternal And Neonatal Outcome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

285 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of fundal pressure in management of the second stage of labor is controversial. The aim of this study is both to evaluate the effectiveness of fundal pressure in shortening the second stage of labor and to examine the related neonatal and maternal outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effcct of Vocalization and Spontaneous Pushing Techniqucs Used in Thc Second Stagc of Labour on Birth Outcomcs: A Randomised Controlled Trial

NCT07316348

Second Stage of Labor Maternal Pushing Techniques Perineal Trauma +1 more

ENROLLING_BY_INVITATION NA

Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes

NCT02676505

The Length of Second Labor Stage in Primigravidae on Maternal & Neonatal Outcomes

UNKNOWN

Maternal Position's Effect on Labor Progression in Occiput Posterior Deliveries

NCT06928038

Labor; Prolonged, Second Stage Delivery Problem

COMPLETED NA

Oxytocin Rest to Reduce Cesarean Delivery

NCT06268431

Prolonged Labor Failed Induction Labor Dystocia

RECRUITING NA

Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)

NCT05560802

Neonatal Complication Labor (Obstetrics)--Complications

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be randomly allocated to two groups by using a computer-generated random number chart: Kristeller maneuver intervention (study) group (n=140) and control group (n=140). Umbilical artery blood gas will obtained to assess the newborn's acid-base status. The umbilical artery levels of creatinine kinase, creatinine kinase with myocardial specific isoform, aspartate amino transferase, alanine amino transferase, lactate dehydrogenase and lactic acid will be measured. Length of episiotomy and length of vagina will be measured at 45 degrees from the midline. Each patient's vaginal laceration, cervical laceration, length of episiotomy and vagina before and after delivery and duration of the second stage of labor in minutes will be recorded. Neonatal information will include: infant birth weight, apgar scores, babies requiring pediatric help, and admission of neonatal intensive care units.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Secons Stage of Labor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

KRISTELLER

Uterine fundal pressure

Group Type EXPERIMENTAL

KRISTELLER

Intervention Type BEHAVIORAL

Control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

KRISTELLER

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnants who were administered for delivery and signed informed consent form were included into the study.

Exclusion Criteria

* Pregnant who required oxytocin augmentation, multiple gestations, pregnant with medical problems (such as asthma, thyroid, cardiac, liver, kidney disease, preeclampsia and diabetes), pregnant with previous caesarean and pregnant whose estimated fetal weight \<2500gr or \>4000gr were not included into the study.

Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes